scispace - formally typeset
R

Roopali Gandhi

Researcher at Brigham and Women's Hospital

Publications -  54
Citations -  4828

Roopali Gandhi is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Multiple sclerosis & T cell. The author has an hindex of 28, co-authored 49 publications receiving 3772 citations. Previous affiliations of Roopali Gandhi include Harvard University.

Papers
More filters
Journal ArticleDOI

Alterations of the human gut microbiome in multiple sclerosis

TL;DR: Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes.
Journal ArticleDOI

The Host Shapes the Gut Microbiota via Fecal MicroRNA

TL;DR: It is shown that fecal microRNA-mediated inter-species gene regulation facilitates host control of the gut microbiota and a potential strategy for manipulating the microbiome is identified.
Journal ArticleDOI

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3+ regulatory T cells

TL;DR: It is found that AhR activation promoted the differentiation of CD4+Foxp3− T cells, which produce IL-10 and control responder T cells through granzyme B, and is a potential target through which functional iTreg cells could be induced in human autoimmune disorders.
Journal ArticleDOI

Role of the innate immune system in the pathogenesis of multiple sclerosis

TL;DR: An overview of potential anti-inflammatory or pro-inflammatory function of DCs, microglial Cells, NK cells, NK-T cells and gamma delta T cells along with their interaction among themselves and with myelin is provided.
Journal ArticleDOI

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells

TL;DR: It is found that orally administered CD3-specific antibody is biologically active in the gut and suppresses autoimmune encephalomyelitis both before induction of disease and at the height of disease.